1. Sperm aneuploidy after testicular cancer treatment: data from a prospective multicenter study performed within the French Centre d’Étude et de Conservation des Oeufs et du Sperme network 
Nathalie Rives, M.D., Marie Walschaerts, Ph.D., Véronique Setif, Li.Sc., Sylvianne Hennebicq, M.D., Jacqueline Saias, M.D., Florence Brugnon, M.D., Jacques Auger, M.D., Isabelle Berthaut, Ph.D., Ethel Szerman, Ph.D., Myriam Daudin, M.D., Louis Bujan, M.D. 
Fertility and Sterility 
Volume 107, Issue 3, Pages e1 (March 2017)
DOI: /j.fertnstert
Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions

2. Supplemental Figure 1
An overview of the selection criteria and number of patients enrolled in the study. FISH = fluorescence in situ hybridization; T3, T6, T12, T24 = 3, 6, 12, and 24 months after end of treatment.
Fertility and Sterility  , e1DOI: ( /j.fertnstert )
Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions